Marie-cristine Kuhnle
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.
Journal: Open forum infectious diseases
Published: October 28, 2025
Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial.
Journal: The Lancet regional health. Western Pacific
Published: September 19, 2022
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Journal: Nature
Published: January 20, 2021
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
Journal: Nature
Published: December 09, 2020
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Journal: Nature
Published: July 16, 2020
Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction.
Journal: Cancer immunology, immunotherapy : CII
Published: October 04, 2013
Control of uterine microenvironment by foxp3(+) cells facilitates embryo implantation.
Journal: Frontiers in immunology
Published: April 30, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026